Aberrant expression and activity of both tumor suppressors and oncogenes have been frequently documented in MCC, yet the paucity of associated mutations suggests that this cancer may lack a defining profile such as the BCR-ABL mutation in chronic myelogenous leukemia. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.